Association between prior cytotoxic therapy, antecedent hematologic disorder, and outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia

HIGHLIGHTS

• who: Corentin Orvain and collaborators from the Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA have published the article: Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia, in the Journal: (JOURNAL) of 10/02/2022
• what: In this analysis, the authors also assessed how the most recent changes in the classification for secondary AML might impact study findings.
• how: AML after AHD as an Independent Prognostic Factor . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.